Bankers Trust’s AbbVie ABBV Stock Holding History

Bankers Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$945K	Buy	16,735 +640	+4%	+$33.6K	0.57%	66
2014 Q1	$828K	Buy	16,095 +3,513	+28%	+$178K	0.53%	68
2013 Q4	$664K	Sell	12,582 -285	-2%	-$14K	0.41%	82
2013 Q3	$575K	Buy	12,867 +344	+3%	+$15.2K	0.41%	83
2013 Q2	$518K	Buy	+12,523	New	+$548K	0.39%	90

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bankers Trust's ABBV Position: Q2 2014 in Review

Bankers Trust increased its AbbVie (ABBV) stake by 4% in Q2 2014, buying an estimated $33.6K and bringing the position to 16,735 shares worth $945K. The position accounts for 0.57% of the portfolio, ranked #66.

Bankers Trust first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Bankers Trust held 16,735 shares of AbbVie worth $945K as of Q2 2014.
Bankers Trust bought 640 AbbVie shares in Q2 2014, an estimated $33.6K.
AbbVie made up 0.57% of Bankers Trust's portfolio in Q2 2014, its #66 holding.
Bankers Trust first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.